Erste Asset Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.8K | Hold |
3,674
| – | – | ﹤0.01% | 851 |
|
|
2025
Q1 | $2.36K | Hold |
3,674
| – | – | ﹤0.01% | 526 |
|
|
2024
Q4 | $2K | Hold |
3,674
| – | – | ﹤0.01% | 532 |
|
|
2024
Q3 | $52.2K | Buy |
+3,674
| New | +$52.2K | ﹤0.01% | 512 |
|
|
2023
Q3 | – | Sell |
-3,674
| Closed | -$57.7K | – | 860 |
|
|
2023
Q2 | $57.7K | Hold |
3,674
| – | – | ﹤0.01% | 529 |
|
|
2023
Q1 | $60.1K | Buy |
+3,674
| New | +$60.1K | ﹤0.01% | 546 |
|
|
2022
Q4 | – | Sell |
-3,674
| Closed | -$47.7K | – | 887 |
|
|
2022
Q3 | $47.7K | Hold |
3,674
| – | – | ﹤0.01% | 532 |
|
|
2022
Q2 | $50.9K | Hold |
3,674
| – | – | ﹤0.01% | 547 |
|
|
2022
Q1 | $52.6K | Hold |
3,674
| – | – | ﹤0.01% | 533 |
|
|
2021
Q4 | $49.9K | Hold |
3,674
| – | – | ﹤0.01% | 517 |
|
|
2021
Q3 | $60.2K | Hold |
3,674
| – | – | ﹤0.01% | 493 |
|
|
2021
Q2 | $61.8K | Hold |
3,674
| – | – | ﹤0.01% | 486 |
|
|
2021
Q1 | $67.1K | Hold |
3,674
| – | – | ﹤0.01% | 471 |
|
|
2020
Q4 | $66.8K | Hold |
3,674
| – | – | ﹤0.01% | 463 |
|
|
2020
Q3 | $65.5K | Hold |
3,674
| – | – | ﹤0.01% | 416 |
|
|
2020
Q2 | $65.9K | Hold |
3,674
| – | – | ﹤0.01% | 392 |
|
|
2020
Q1 | $55.8K | Hold |
3,674
| – | – | ﹤0.01% | 371 |
|
|
2019
Q4 | $72.5K | Hold |
3,674
| – | – | ﹤0.01% | 376 |
|
|
2019
Q3 | $63.2K | Buy |
+3,674
| New | +$63.2K | ﹤0.01% | 371 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 837 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 839 |
|